Summary
Using Epstein-Barr virus B cell clones and antigen-specific T cell clones, we asked how antigenantibody complexes are handled by B cells . We found that the only B cells capable of efficient presentation of antigen-antibody complexes are those that bind the complexes via membrane immunoglobulin, i .e., rheumatoid factor-producing B cells and, to a lower extent, antigen-specific B cells. On the contrary, nonspecific B cells, although capable ofbinding antigen-antibody complexes, fail to present them to T cells . Thus, rheumatoid factor B cells can present any antigen in the context ofan immune complex and be triggered by T cells specific for a variety of foreign antigens. These results demonstrate a mechanism of intermolecular help that may be responsible for the production of rheumatoid factor and possibly of other types of autoantibodies.
B and T Cell Clones. PBMC from a donor recently boosted with tetanus toxoid (TT) were transformed with EBV and cloned by limiting dilution as described (3) . AntiTT antibodies or RF were detected by a reverse Western blot technique. Briefly, supernatants of limiting dilution cultures were blotted on nitrocellulose paper and blocked with 0 .5% casein. The specific antibodies were detected using either biotinylated TT (a gift of Dr. J . Nagel, RIVM, Bilthoven, The Netherlands) or biotinylated heat-aggregated human IgG followed by avidin-peroxidase (Southern Biotechnologies, Birmingham, AL). After washing, filters were developed using 3,3'-diaminobenzidine tetrahydrochloride. The RF activity of the selected 487 clones was confirmed by testing the supernatants in standard RF ELISAs using plates coated with rabbit IgG. From the same donor, we also isolated two DR6-restricted TTspecific T cell clones as described (3) .
Proliferation Assay. 2 x 104 T cells were cultured with 2 x 104 irradiated (6,000 rad) EBV B cells in 200 Al RPMI-10% FCS in 96-well flat-bottomed plates . The cultures were stimulated with different concentrations of TT in the presence or absence of anti-TT antibodies (Schweizerisches Seruminstitut, Bern, Switzerland). In all cases, TT and antibodies were added to the culture wells 30 min before adding the cells to allow complex formation . In some experiments, complexes were formed at a threefold antibody excess and titrated in the cultures. After 2 d, 1 p.Ci [3H]thymidine (sp act, 5 Ci/mM) was added and the radioactivity incorporated was measured after an additional 16 h by liquid scintillation counting. Data represent the mean of triplicate cultures. The background of B cells alone (<1,000 cpm) was subtracted .
Detection of Cell-bound Immune Complexes. RP-specific or nonspecific B cell clones were pulsed at 0°C for 30 min with immune complexes containing biotinylated TT (1 Wg/ml) . The cells were washed and stained with PE-avidin (Southern Biotechnologies) and sorted on a FRCS 440 (Becton Dickinson & Co., Mountain View, CA) . We first compared these B cell clones for their capacity to present TT to T cells in the absence of specific antibody. TT (ng/ml) Ab/TT ratio ture antigen via mIg, are able to present low concentrations of TT while RF B cells and nonspecific B cells are not effective at TT concentrations <300 ng/ml. We then compared the same B cells for their capacity to present a fixed concentration of TT (10 ng/ml) in the presence of increasing concentrations of a human polyclonal anti-TT antiserum . Fig . 1 B shows that RF B cells and TTspecific B cells have a strikingly opposite behavior. RF B cells, which were not effective in the absence of antibody, acquired the capacity to present TT in the presence of antiTT Presentation by RF B cells was detected at an antibody/TT ratio of 1, was optimal at a ratio of 3, and leveled out at higher antibody concentrations. In contrast, TTspecific B cells progressively lost antigen-presenting capacity upon increase of the concentration of soluble antibody in culture. The high antibody concentration required to inhibit presentation by TT specific B cells is not surprising, since only a small fraction of the polyclonal antibody will compete with mIg for binding to the same epitope. Fig. 1 B also shows that nonspecific B cells did not acquire antigen-presenting capacity in the presence of antiTT antibody.
Finally, we compared the three B cell clones for their capacity to present different concentrations of immune com- Failure ofNonspecific B Cells to Present Surface-bound AntigenAntibody Complexes. To investigate whether the failure of nonspecific B cells to present antigen-antibody complexes was due to their inability to bind these complexes, we incubated nonspecific and RF B cells at 0°C with immune complexes containing biotinylated TT, stained the cells with avidin-PE, sorted the cells that had bound similar amounts of TT, and tested their ability to trigger TTspecific T cell clones. Fig. 2 shows that, although both cell types had bound similar amounts of TT, only the RF B cells were able to present TT, while nonspecific B cells could not . Appropriate controls showed that nonspecific B cells were able to present TT added in culture at high concentrations (10 Fig/ml ) (data not shown, and reference 3) .
Discussion
Our results indicate that the only B cells capable of presenting with high efficiency an antigen (TT) complexed with IgG antibodies are those that bind the immune complexes via mIg, i .e., RF B cells, which bind the Fc portion of IgG, and TTspecific B cells, which bind TT epitopes still available. The failure of nonspecific B cells to present immune complexes most likely bound to Fc-yR is in agreement with similar reports on mouse B cells (7) and with the fact that the FcyRII isoform on B cells is different from that on monocytes and is not internalized via coated pits (8) .
Altogether, these data indicate that in B cells only the mIgmediated pathway allows efficient uptake of antigen or IgG immune complexes . This provides a quantitative framework for understanding the differential handling of antigen by B cells in the immune response. In contrast to macrophages, B cells are inefficient at capturing antigen by nonspecific means, such as pinocytosis (9) or FcyR (5, 6) . Thus, in the absence of antibodies, antigen is selectively captured and presented by macrophages and by specific B cells, leading to T cell priming and to specific antibody secretion. The antibodies produced form immune complexes that would thus divert antigen from specific B cells and focus it onto macrophages and RF B cells. The latter will thus become the selected B cell target for T cell help. This mechanism explains the negative feedback of antibody on the antibody response (10) and, in addition, the transient production of RF in the secondary immune response or upon immunization with immune complexes (11) (12) (13) .
Different mechanisms have been proposed to explain the production of autoantibodies, such as polyclonal B cell activation and molecular mimicry. An alternative possibility is that the formation of a complex between self and foreign molecules may result in the focussing of T cell help onto autoreactive B cells. Zinkernagel et al . (14) have recently shown that in vesicular stomatitis virus (VSV)-G protein transgenic
